Invivyd (NASDAQ:IVVD) said its first quarter of 2026 was marked by continued progress in its pivotal COVID-19 antibody ...

The head of the Food and Drug Administration, Dr. Marty Makary, is resigning after a rocky tenure that drew months of ...

During a tumultuous 13-month tenure at the FDA, Makary pursued a wide range of ambitious initiatives. Going forward, their status under the next commissioner is unclear.

The pandemic-era bonanza is firmly in the rearview mirror at BioNTech, replaced by a searing quarterly loss and a sweeping ...

Achieved Q1 2026 PEMGARDA® (pemivibart) net product revenue of $13.7 million, representing 22% growth versus Q1 2025 net product revenue of $11.3 ...

The Centers for Disease Control and Prevention is gathering feedback on a proposal that would create a medical code to track ...

I n December 2020, mRNA vaccines leapt into the limelight as a response to the COVID-19 pandemic. To date, millions of people ...

The government’s case rests on informal email exchanges routed through a personal Gmail account, collegial scientific coordination with EcoHealth Alliance and the acceptance of two bottles of wine ...

Then on Tuesday Dr. Marty Makary resigned as head of the FDA, leaving another major health agency with only an acting commissioner. Makary’s departure widens a leadership gap that has plagued HHS ...

A public health expert explains why the United States is repeating the same mistake with the Hantavirus response as with ...

The 2026 Sabin Awards were presented yesterday at the National Academy of Sciences building in Washington, D.C., with Professor Ugur Sahin, MD, and Professor Özlem Türeci, MD, receiving the Sabin ...